Centers for Disease Control and Prevention, San Juan, Puerto Rico.
Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
J Infect Dis. 2022 Nov 28;226(11):1949-1958. doi: 10.1093/infdis/jiac165.
We evaluated clinical and laboratory findings among patients with nonsevere or severe dengue in Puerto Rico to examine whether clinical manifestations vary by age.
During 2012-2014, we enrolled patients who arrived at the emergency department with fever or history of fever within 7 days of presentation. Serum samples were tested for dengue virus (DENV) by reverse transcriptase-polymerase chain reaction (RT-PCR) and IgM enzyme-linked immunosorbent assay (ELISA). Severe dengue was defined as severe plasma leakage or shock, severe bleeding, or organ involvement at presentation, during hospitalization, or follow-up.
Of 1089 dengue patients identified, 281 (26%) were severe. Compared to those with nonsevere dengue, patients with severe dengue were more often aged 10-19 years (55% vs 40%, P < .001) and hospitalized (87% vs 30%, P < .001). Severe plasma leakage or shock was more common among children aged 0-9 (59%) or 10-19 years (86%) than adults (49%) (P < .01). Severe bleeding was less common among 10-19 year olds (24%) compared to 0-9 year olds (45%) and adults (52%; P < .01).
Severe plasma leakage was the most common presentation among children, highlighting important differences from adults. Vaccination against dengue could help prevent severe dengue among children in Puerto Rico.
我们评估了波多黎各非重症和重症登革热患者的临床和实验室检查结果,以研究临床表现是否因年龄而异。
在 2012-2014 年期间,我们招募了因发热或就诊前 7 天内有发热史而到急诊科就诊的患者。通过逆转录-聚合酶链反应(RT-PCR)和 IgM 酶联免疫吸附试验(ELISA)检测血清样本中的登革病毒(DENV)。重症登革热定义为就诊时、住院期间或随访期间出现严重血浆渗漏或休克、严重出血或器官受累。
在确定的 1089 例登革热患者中,281 例(26%)为重症。与非重症登革热患者相比,重症登革热患者更常为 10-19 岁(55%比 40%,P<.001)和住院患者(87%比 30%,P<.001)。0-9 岁儿童(59%)或 10-19 岁儿童(86%)发生严重血浆渗漏或休克的比例高于成人(49%)(P<.01)。10-19 岁青少年发生严重出血的比例(24%)低于 0-9 岁儿童(45%)和成人(52%)(P<.01)。
严重血浆渗漏是儿童中最常见的表现,这与成人有重要的区别。在波多黎各,针对登革热的疫苗接种可能有助于预防儿童重症登革热。